
Neutrogena Ultra Sheer: “Sunscreen You Can’t See” with John Cena
Turns out John Cena did show up…but just like our sunscreen, we can’t see him.
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Pending
Turns out John Cena did show up…but just like our sunscreen, we can’t see him.
Tanya Gazdik, Media Post
Underwear seller strips a number of marketing claims after a TINA.org inquiry.
TINA.org notifies electric vehicle maker for second time in three years.
Jamie L. LaReau, Detroit Free Press